Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: A prospective study

Inflammatory Bowel Diseases

Volumn 18, Issue 6, 2012, Pages 1042-1047

  Fiorino, Gionata ^a   Peyrin Biroulet, Laurent ^b   Naccarato, Patrizia ^a   Szabò, Hajnalka ^a   Sociale, Orsola R ^a   Vetrano, Stefania ^a   Fries, Walter ^c   Montanelli, Alessandro ^a   Repici, Alessandro ^a   Malesci, Alberto ^a,d   Danese, Silvio ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Crohn's disease; inflammatory bowel disease; pneumococcal; ulcerative colitis; vaccination

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; MESALAZINE; PNEUMOCOCCUS VACCINE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIBODY TITER; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; HYPEREMIA; HYPERPYREXIA; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVIEW; RISK; RISK FACTOR; ULCERATIVE COLITIS; VACCINATION;

ADULT; AGED; ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; PROGNOSIS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84861333524     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21800     Document Type: Review

References (27)

1. Danese S, Fiocchi C,. Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol. 2006; 12: 4807-4212.
2. Fiocchi C,. Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions. Am J Physiol. 1997; 273: G769-775.
3. Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohn's Colitis. 2010; 4: 28-62.
4. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010; 362: 1383-1395.
5. Toruner M, Loftus EV Jr, Harmsen WS, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008; 134: 929-936.
6. Rahier JF, Ben-Horin S, Chowers Y, et al. European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2009; 3: 47-91.
7. Wasan SK, Baker SE, Skolnik PR, et al. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol. 2010; 105: 1231-1238.
8. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997; 46: 1-24.
9. Garcia-Vidal C, Carratalà J, Fernández-Sabé N, et al. Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clin Microbiol Infect. 2009; 15: 1033-1038.
10. Iliopoulos AG, Tsokos GC,. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum. 1996; 25: 318-336.
11. Listing J, Strangfeld A, Kary S, et al. Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum. 2005; 52: 3403-3412.
12. Askling J, Fored CM, Brandt L, et al. Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists. Ann Rheum Dis. 2007; 66: 1339-1344.
13. Melmed GY, Ippoliti AF, Papadakis KA, et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol. 2006; 101: 1834-1840.
14. Butler JC, Shapiro ED, Carlone GM,. Pneumococcal vaccines: history, current status, and future directions. Am J Med. 1999; 107: 69S-76S.
15. Targonski PV, Poland GA,. Pneumococcal vaccination in adults: recommendations, trends, and prospects. Cleve Clin J Med. 2007; 14: 401-406.
16. Jeurissen A, Moens L, Raes M, et al. Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens. Clin Chem. 2007; 53: 505-510.
17. Melmed GY, Agarwal N, Frenck RW, et al. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am J Gastroenterol. 2010; 105: 148-154.
18. Rahier JF, Van Gompel A, Van Ranst M, et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford). 2010; 49: 1815-1827.
19. Harvey RF, Bradshaw JM,. A simple index of Crohn's-disease activity. Lancet. 1980; 1: 1134-1135.
20. Sutherland LR, Martin F, Greer S, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology. 1987; 92: 1894-1898.
21. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006; 55: 749-753.
22. Dotan I, Vigodman S, Malter L, et al. Azathioprine/6-mercaptopurine therapy has no significant effect on cellular or humoral immune responses in patients with inflammatory bowel disease. Gastroenterology. 2007; 132: A-51.
23. Mamula P, Markowitz JE, Piccoli DA, et al. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007; 5: 851-856.
24. Romanowska M, Banaszkiewicz A, Nowak I, et al. Immunization against influenza during the 2005/2006 epidemic season and the humoral response in children with diagnosed inflammatory bowel disease (IBD). Med Sci Monit. 2010; 16: CR433-439.
25. Kapetanovic MC, Saxne T, Sjöholm A, et al. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford). 2006; 45: 106-111.
26. Brezinschek HP, Hofstaetter T, Leeb BF, et al. Immunization of patients with rheumatoid arthritis with antitumor necrosis factor alpha therapy and methotrexate. Curr Opin Rheumatol. 2008; 20: 295-299.
27. Visvanathan S, Keenan GF, Baker DG, et al. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. J Rheumatol. 2007; 34: 952-957.